Global CRISPR And CRISPR-Associated (Cas) Genes Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global CRISPR And CRISPR-Associated (Cas) Genes market size will reach 3,386.46 Million USD in 2025 and is projected to reach 21,898.63 Million USD by 2032, with a CAGR of 30.56% (2025-2032). Notably, the China CRISPR And CRISPR-Associated (Cas) Genes market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and CRISPR-associated (Cas) genes are part of a bacterial and archaeal defense system against viruses and foreign genetic elements. CRISPR is a region in the bacterial genome containing short, repetitive sequences interspersed with unique spacer sequences derived from viral DNA. When a bacterium is infected by a virus, it captures a piece of the viral DNA and incorporates it into its CRISPR region. The CRISPR-associated (Cas) genes encode enzymes, such as Cas9, that use the spacer sequences as guides to identify and cleave specific viral DNA during subsequent infections, providing an adaptive immune response against the invading virus. In recent years, scientists have harnessed the CRISPR-Cas system as a powerful gene-editing tool for precise modification of DNA in various organisms, including plants, animals, and humans. The CRISPR-Cas technology has revolutionized biotechnology and genetic research, making it more accessible and efficient for applications like gene therapy, genetic engineering, and disease treatment. Its potential in various fields has led to significant advancements and opened up new possibilities in the realm of genetics and molecular biology.
The major global suppliers of CRISPR And CRISPR-Associated (Cas) Genes include Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Cellectis, Horizon Discovery, Sigma Aldrich, Precision Biosciences, Genscript, Lonza Group Limited, Sangamo Biosciences, Integrated DNA Technologies, New England Biolabs, Origene Technologies, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of CRISPR And CRISPR-Associated (Cas) Genes. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global CRISPR And CRISPR-Associated (Cas) Genes market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the CRISPR And CRISPR-Associated (Cas) Genes market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of CRISPR And CRISPR-Associated (Cas) Genes industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of CRISPR And CRISPR-Associated (Cas) Genes Include:
Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics
Cellectis
Horizon Discovery
Sigma Aldrich
Precision Biosciences
Genscript
Lonza Group Limited
Sangamo Biosciences
Integrated DNA Technologies
New England Biolabs
Origene Technologies
CRISPR And CRISPR-Associated (Cas) Genes Product Segment Include:
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
CRISPR And CRISPR-Associated (Cas) Genes Product Application Include:
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global CRISPR And CRISPR-Associated (Cas) Genes Industry PESTEL Analysis
Chapter 3: Global CRISPR And CRISPR-Associated (Cas) Genes Industry Porter's Five Forces Analysis
Chapter 4: Global CRISPR And CRISPR-Associated (Cas) Genes Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global CRISPR And CRISPR-Associated (Cas) Genes Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, CRISPR And CRISPR-Associated (Cas) Genes Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global CRISPR And CRISPR-Associated (Cas) Genes market size will reach 3,386.46 Million USD in 2025 and is projected to reach 21,898.63 Million USD by 2032, with a CAGR of 30.56% (2025-2032). Notably, the China CRISPR And CRISPR-Associated (Cas) Genes market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and CRISPR-associated (Cas) genes are part of a bacterial and archaeal defense system against viruses and foreign genetic elements. CRISPR is a region in the bacterial genome containing short, repetitive sequences interspersed with unique spacer sequences derived from viral DNA. When a bacterium is infected by a virus, it captures a piece of the viral DNA and incorporates it into its CRISPR region. The CRISPR-associated (Cas) genes encode enzymes, such as Cas9, that use the spacer sequences as guides to identify and cleave specific viral DNA during subsequent infections, providing an adaptive immune response against the invading virus. In recent years, scientists have harnessed the CRISPR-Cas system as a powerful gene-editing tool for precise modification of DNA in various organisms, including plants, animals, and humans. The CRISPR-Cas technology has revolutionized biotechnology and genetic research, making it more accessible and efficient for applications like gene therapy, genetic engineering, and disease treatment. Its potential in various fields has led to significant advancements and opened up new possibilities in the realm of genetics and molecular biology.
The major global suppliers of CRISPR And CRISPR-Associated (Cas) Genes include Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Cellectis, Horizon Discovery, Sigma Aldrich, Precision Biosciences, Genscript, Lonza Group Limited, Sangamo Biosciences, Integrated DNA Technologies, New England Biolabs, Origene Technologies, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of CRISPR And CRISPR-Associated (Cas) Genes. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global CRISPR And CRISPR-Associated (Cas) Genes market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the CRISPR And CRISPR-Associated (Cas) Genes market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of CRISPR And CRISPR-Associated (Cas) Genes industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of CRISPR And CRISPR-Associated (Cas) Genes Include:
Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics
Cellectis
Horizon Discovery
Sigma Aldrich
Precision Biosciences
Genscript
Lonza Group Limited
Sangamo Biosciences
Integrated DNA Technologies
New England Biolabs
Origene Technologies
CRISPR And CRISPR-Associated (Cas) Genes Product Segment Include:
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
CRISPR And CRISPR-Associated (Cas) Genes Product Application Include:
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global CRISPR And CRISPR-Associated (Cas) Genes Industry PESTEL Analysis
Chapter 3: Global CRISPR And CRISPR-Associated (Cas) Genes Industry Porter's Five Forces Analysis
Chapter 4: Global CRISPR And CRISPR-Associated (Cas) Genes Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global CRISPR And CRISPR-Associated (Cas) Genes Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, CRISPR And CRISPR-Associated (Cas) Genes Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 CRISPR And CRISPR-Associated (Cas) Genes Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 CRISPR And CRISPR-Associated (Cas) Genes Product by Type
- 1.2.1 Genome Editing
- 1.2.2 Genetic engineering
- 1.2.3 gRNA Database/Gene Librar
- 1.2.4 CRISPR Plasmid
- 1.2.5 Human Stem Cells
- 1.2.6 Genetically Modified Organisms/Crops
- 1.2.7 Cell Line Engineering
- 1.3 CRISPR And CRISPR-Associated (Cas) Genes Product by Application
- 1.3.1 Biotechnology Companies
- 1.3.2 Pharmaceutical Companies
- 1.3.3 Academic Institutes
- 1.3.4 Research and Development Institutes
- 1.4 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size Analysis (2020-2032)
- 1.5 CRISPR And CRISPR-Associated (Cas) Genes Market Development Status and Trends
- 1.5.1 CRISPR And CRISPR-Associated (Cas) Genes Industry Development Status Analysis
- 1.5.2 CRISPR And CRISPR-Associated (Cas) Genes Industry Development Trends Analysis
- 2 CRISPR And CRISPR-Associated (Cas) Genes Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 CRISPR And CRISPR-Associated (Cas) Genes Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global CRISPR And CRISPR-Associated (Cas) Genes Market Analysis by Country
- 4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Analysis by Country (2020-2025)
- 4.1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States CRISPR And CRISPR-Associated (Cas) Genes Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany CRISPR And CRISPR-Associated (Cas) Genes Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan CRISPR And CRISPR-Associated (Cas) Genes Market Revenue and Growth Rate (2020-2032)
- 4.5 China CRISPR And CRISPR-Associated (Cas) Genes Market Revenue and Growth Rate (2020-2032)
- 4.6 France CRISPR And CRISPR-Associated (Cas) Genes Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. CRISPR And CRISPR-Associated (Cas) Genes Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea CRISPR And CRISPR-Associated (Cas) Genes Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada CRISPR And CRISPR-Associated (Cas) Genes Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy CRISPR And CRISPR-Associated (Cas) Genes Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia CRISPR And CRISPR-Associated (Cas) Genes Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico CRISPR And CRISPR-Associated (Cas) Genes Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil CRISPR And CRISPR-Associated (Cas) Genes Market Revenue and Growth Rate (2020-2032)
- 4.14 India CRISPR And CRISPR-Associated (Cas) Genes Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam CRISPR And CRISPR-Associated (Cas) Genes Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand CRISPR And CRISPR-Associated (Cas) Genes Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa CRISPR And CRISPR-Associated (Cas) Genes Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market Revenue by Key Suppliers (2021-2025)
- 5.2 CRISPR And CRISPR-Associated (Cas) Genes Competitive Landscape Analysis and Market Dynamic
- 5.2.1 CRISPR And CRISPR-Associated (Cas) Genes Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 CRISPR And CRISPR-Associated (Cas) Genes Market Analysis by Type
- 6.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Thermo Fisher Scientific
- 7.1.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Product Portfolio
- 7.1.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Editas Medicine
- 7.2.1 Editas Medicine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Product Portfolio
- 7.2.3 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Caribou Biosciences
- 7.3.1 Caribou Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Product Portfolio
- 7.3.3 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 CRISPR therapeutics
- 7.4.1 CRISPR therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 CRISPR therapeutics CRISPR And CRISPR-Associated (Cas) Genes Product Portfolio
- 7.4.3 CRISPR therapeutics CRISPR And CRISPR-Associated (Cas) Genes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Intellia therapeutics
- 7.5.1 Intellia therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Intellia therapeutics CRISPR And CRISPR-Associated (Cas) Genes Product Portfolio
- 7.5.3 Intellia therapeutics CRISPR And CRISPR-Associated (Cas) Genes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Cellectis
- 7.6.1 Cellectis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Cellectis CRISPR And CRISPR-Associated (Cas) Genes Product Portfolio
- 7.6.3 Cellectis CRISPR And CRISPR-Associated (Cas) Genes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Horizon Discovery
- 7.7.1 Horizon Discovery Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Horizon Discovery CRISPR And CRISPR-Associated (Cas) Genes Product Portfolio
- 7.7.3 Horizon Discovery CRISPR And CRISPR-Associated (Cas) Genes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Sigma Aldrich
- 7.8.1 Sigma Aldrich Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Sigma Aldrich CRISPR And CRISPR-Associated (Cas) Genes Product Portfolio
- 7.8.3 Sigma Aldrich CRISPR And CRISPR-Associated (Cas) Genes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Precision Biosciences
- 7.9.1 Precision Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Precision Biosciences CRISPR And CRISPR-Associated (Cas) Genes Product Portfolio
- 7.9.3 Precision Biosciences CRISPR And CRISPR-Associated (Cas) Genes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Genscript
- 7.10.1 Genscript Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Genscript CRISPR And CRISPR-Associated (Cas) Genes Product Portfolio
- 7.10.3 Genscript CRISPR And CRISPR-Associated (Cas) Genes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Lonza Group Limited
- 7.11.1 Lonza Group Limited Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Lonza Group Limited CRISPR And CRISPR-Associated (Cas) Genes Product Portfolio
- 7.11.3 Lonza Group Limited CRISPR And CRISPR-Associated (Cas) Genes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Sangamo Biosciences
- 7.12.1 Sangamo Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Sangamo Biosciences CRISPR And CRISPR-Associated (Cas) Genes Product Portfolio
- 7.12.3 Sangamo Biosciences CRISPR And CRISPR-Associated (Cas) Genes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Integrated DNA Technologies
- 7.13.1 Integrated DNA Technologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Integrated DNA Technologies CRISPR And CRISPR-Associated (Cas) Genes Product Portfolio
- 7.13.3 Integrated DNA Technologies CRISPR And CRISPR-Associated (Cas) Genes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 New England Biolabs
- 7.14.1 New England Biolabs Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 New England Biolabs CRISPR And CRISPR-Associated (Cas) Genes Product Portfolio
- 7.14.3 New England Biolabs CRISPR And CRISPR-Associated (Cas) Genes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.15 Origene Technologies
- 7.15.1 Origene Technologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 Origene Technologies CRISPR And CRISPR-Associated (Cas) Genes Product Portfolio
- 7.15.3 Origene Technologies CRISPR And CRISPR-Associated (Cas) Genes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 CRISPR And CRISPR-Associated (Cas) Genes Industry Chain Analysis
- 8.2 CRISPR And CRISPR-Associated (Cas) Genes Product Downstream Application Analysis
- 8.2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Forecast by Application (2020-2032)
- 8.3 CRISPR And CRISPR-Associated (Cas) Genes Typical Downstream Customers
- 8.4 CRISPR And CRISPR-Associated (Cas) Genes Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
